BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Holding BBIO?
Track your performance easily

BridgeBio Pharma (BBIO) Financial Statements

993 Followers

BridgeBio Pharma Financial Overview

BridgeBio Pharma's market cap is currently ―. The company's EPS TTM is $-2.636; its P/E ratio is -10.28; BridgeBio Pharma is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 2.17M$ 211.12M$ 1.75M$ 4.09M$ 1.64M
Gross Profit$ 1.57M$ 210.52M$ 496.00K$ 3.49M$ 1.04M
EBIT$ -52.61M$ -12.69M$ -150.06M$ -159.18M$ -140.11M
EBITDA$ -51.03M$ -11.09M$ -148.47M$ -157.54M$ -138.47M
Net Income Common Stockholders$ -73.46M$ -35.22M$ -168.15M$ -177.00M$ -157.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 447.77M$ 519.69M$ 434.88M$ 543.26M$ 383.79M
Total Assets$ 794.38M$ 849.33M$ 546.38M$ 655.01M$ 503.66M
Total Debt$ 447.13M$ 447.56M$ 459.55M$ 455.67M$ 455.19M
Net Debt$ -642.00K$ -72.13M$ 24.67M$ -87.59M$ 71.39M
Total Liabilities$ 594.09M$ 1.89B$ 1.89B$ 1.85B$ 575.19M
Stockholders Equity$ -1.09B$ -1.05B$ -1.35B$ -1.21B$ -1.36B
Cash Flow-
Free Cash Flow$ 72.26M$ -221.03M$ -125.25M$ -145.66M$ -113.78M
Operating Cash Flow$ 74.70M$ -219.54M$ -124.82M$ -145.23M$ -113.35M
Investing Cash Flow$ 3.04M$ 22.75M$ -66.00K$ 37.68M$ 4.12M
Financing Cash Flow$ -5.73M$ 279.55M$ -4.52M$ 307.04M$ -1.23M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

BridgeBio Pharma Debt to Assets

BridgeBio Pharma Cash Flow

BridgeBio Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis